Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1969 2
1976 1
1991 1
1996 1
1998 1
1999 3
2000 2
2001 2
2002 3
2003 1
2004 6
2006 1
2007 2
2008 2
2009 1
2010 5
2011 1
2012 3
2013 4
2014 6
2015 2
2016 7
2017 7
2018 4
2019 3
2020 5
2021 12
2022 7
2023 10
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
DeSUMOylation of chromatin-bound proteins limits the rapid transcriptional reprogramming induced by daunorubicin in acute myeloid leukemias.
Boulanger M, Aqrouq M, Tempé D, Kifagi C, Ristic M, Akl D, Hallal R, Carusi A, Gabellier L, de Toledo M, Sigurdsson JO, Kaoma T, Andrieu-Soler C, Forné T, Soler E, Hicheri Y, Gueret E, Vallar L, Olsen JV, Cartron G, Piechaczyk M, Bossis G. Boulanger M, et al. Among authors: de toledo m. Nucleic Acids Res. 2023 Sep 8;51(16):8413-8433. doi: 10.1093/nar/gkad581. Nucleic Acids Res. 2023. PMID: 37462077 Free PMC article.
The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemias.
Paolillo R, Boulanger M, Gâtel P, Gabellier L, De Toledo M, Tempé D, Hallal R, Akl D, Moreaux J, Baik H, Gueret E, Recher C, Sarry JE, Cartron G, Piechaczyk M, Bossis G. Paolillo R, et al. Among authors: de toledo m. Haematologica. 2022 Nov 1;107(11):2562-2575. doi: 10.3324/haematol.2021.279889. Haematologica. 2022. PMID: 35172562 Free PMC article.
Outcomes from a Spanish Expanded Access Program on cannabidiol treatment in pediatric and adult patients with epilepsy.
Villanueva V, García-Ron A, Smeyers P, Arias E, Soto V, García-Peñas JJ, González-Alguacil E, Sayas D, Serrano-Castro P, Garces M, Hampel K, Tomás M, Lara J, de Toledo M, Barceló I, Aledo-Serrano A, Gil-Nagel A, Iacampo L, Falip M, Saiz-Diaz RA, Gómez-Ibañez A, Sopelana D, Sanchez-Larsen A, López-González FJ. Villanueva V, et al. Among authors: de toledo m. Epilepsy Behav. 2022 Dec;137(Pt A):108958. doi: 10.1016/j.yebeh.2022.108958. Epub 2022 Oct 29. Epilepsy Behav. 2022. PMID: 36327646
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.
Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. Front Neurol. 2021. PMID: 34659081 Free PMC article.
Functionalized Cellulose Nanocrystals for Cellular Labeling and Bioimaging.
Raja S, Hamouda AEI, de Toledo MAS, Hu C, Bernardo MP, Schalla C, Leite LSF, Buhl EM, Dreschers S, Pich A, Zenke M, Mattoso LHC, Sechi A. Raja S, et al. Among authors: de toledo mas. Biomacromolecules. 2021 Feb 8;22(2):454-466. doi: 10.1021/acs.biomac.0c01317. Epub 2020 Dec 7. Biomacromolecules. 2021. PMID: 33284004
Extensive pharmacokinetic variability of Levetiracetam. ¿Are doctors aware?
de Toledo M, de la Fuente E, Ramos C, Ferreiros-Martinez R, Muro I, Vieira Campos A, de Toledo MP, Lagares A, Sobrado M, Ovejero-Benito MC. de Toledo M, et al. Among authors: de toledo mp. Epilepsy Res. 2022 Nov;187:107029. doi: 10.1016/j.eplepsyres.2022.107029. Epub 2022 Sep 29. Epilepsy Res. 2022. PMID: 36272308
101 results